PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $875,328 | -2.5% | 396,076 | +12.0% | 0.00% | 0.0% |
| Q1 2023 | $897,888 | +22.3% | 353,499 | -10.0% | 0.00% | 0.0% |
| Q4 2022 | $734,341 | -7.6% | 392,696 | +26.9% | 0.00% | 0.0% |
| Q3 2022 | $795,000 | +248.7% | 309,564 | +161.9% | 0.00% | – |
| Q2 2022 | $228,000 | 0.0% | 118,209 | +53.7% | 0.00% | – |
| Q1 2022 | $228,000 | +78.1% | 76,931 | +170.8% | 0.00% | – |
| Q4 2021 | $128,000 | -52.6% | 28,413 | -48.8% | 0.00% | – |
| Q3 2021 | $270,000 | -63.0% | 55,507 | -48.1% | 0.00% | -100.0% |
| Q2 2021 | $729,000 | -52.4% | 106,908 | -50.7% | 0.00% | 0.0% |
| Q1 2021 | $1,530,000 | -38.2% | 216,653 | -45.2% | 0.00% | -50.0% |
| Q4 2020 | $2,477,000 | -25.5% | 395,661 | -35.6% | 0.00% | -33.3% |
| Q3 2020 | $3,325,000 | -37.5% | 614,554 | -39.7% | 0.00% | -50.0% |
| Q2 2020 | $5,316,000 | +200.8% | 1,018,465 | +81.5% | 0.01% | +100.0% |
| Q1 2020 | $1,767,000 | +68.6% | 561,124 | +115.7% | 0.00% | +200.0% |
| Q4 2019 | $1,048,000 | +1243.6% | 260,083 | +1343.3% | 0.00% | – |
| Q3 2019 | $78,000 | -78.3% | 18,020 | -10.2% | 0.00% | – |
| Q4 2017 | $359,000 | +116.3% | 20,071 | +85.7% | 0.00% | – |
| Q4 2016 | $166,000 | -40.5% | 10,806 | -49.6% | 0.00% | – |
| Q3 2016 | $279,000 | -92.6% | 21,456 | -78.2% | 0.00% | -100.0% |
| Q4 2014 | $3,790,000 | – | 98,315 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|